Literature DB >> 22057975

Assessing anxious features in depressed outpatients.

Shawn M McClintock1, Mustafa M Husain, Ira H Bernstein, Stephen R Wisniewski, Madhukar H Trivedi, David Morris, Jonathan Alpert, Diane Warden, James F Luther, Susan G Kornstein, Melanie M Biggs, Maurizio Fava, A John Rush.   

Abstract

Both the 17-item Hamilton Rating Scale for Depression (HRSD(17)) and 30-item Inventory of Depressive Symptomatology - Clinician-rated (IDS-C(30) ) contain a subscale that assesses anxious symptoms. We used classical test theory and item response theory methods to assess and compare the psychometric properties of the two anxiety subscales (HRSD(ANX) and IDS-C(ANX)) in a large sample (N = 3453) of outpatients with non-psychotic major depressive disorder in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Approximately 48% of evaluable participants had at least one concurrent anxiety disorder by the self-report Psychiatric Diagnostic Screening Questionnaire (PDSQ). The HRSD(ANX) and IDS-C(ANX) were highly correlated (r = 0.75) and both had moderate internal consistency given their limited number of items (HRSD(ANX) Cronbach's alpha = 0.48; IDS-C(ANX) Cronbach's alpha = 0.58). The optimal threshold for ascribing the presence/absence of anxious features was found at a total score of eight or nine for the HRSD(ANX) and seven or eight for the IDS-C(ANX) . It would seem beneficial to delete item 17 (loss of insight) from the HRSD(ANX) as it negatively correlated with the scale's total score. Both the HRSD(ANX) and IDS-C(ANX) subscales have acceptable psychometric properties and can be used to identify anxious features for clinical or research purposes.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057975      PMCID: PMC3708141          DOI: 10.1002/mpr.353

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  50 in total

Review 1.  Understanding sensitivity and specificity with the right side of the brain.

Authors:  Tze-Wey Loong
Journal:  BMJ       Date:  2003-09-27

2.  A clinically useful anxiety outcome scale.

Authors:  Mark Zimmerman; Iwona Chelminski; Diane Young; Kristy Dalrymple
Journal:  J Clin Psychiatry       Date:  2010-03-09       Impact factor: 4.384

3.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

4.  A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire.

Authors:  M Zimmerman; J I Mattia
Journal:  Arch Gen Psychiatry       Date:  2001-08

5.  Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey.

Authors:  R C Kessler; C B Nelson; K A McGonagle; J Liu; M Swartz; D G Blazer
Journal:  Br J Psychiatry Suppl       Date:  1996-06

6.  Psychopathological dimensions of depression: a factor study of the 17-item Hamilton depression rating scale in unipolar depressed outpatients.

Authors:  P Pancheri; A Picardi; M Pasquini; P Gaetano; M Biondi
Journal:  J Affect Disord       Date:  2002-02       Impact factor: 4.839

7.  The Inventory for Depressive Symptomatology (IDS): preliminary findings.

Authors:  A J Rush; D E Giles; M A Schlesser; C L Fulton; J Weissenburger; C Burns
Journal:  Psychiatry Res       Date:  1986-05       Impact factor: 3.222

8.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

9.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

10.  Item Response Analysis of the Inventory of Depressive Symptomatology.

Authors:  Ira H Bernstein; A John Rush; Carmody J Thomas; Ada Woo; Madhukar H Trivedi
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

View more
  8 in total

1.  Pharmacologic treatment of dimensional anxious depression: a review.

Authors:  Dawn F Ionescu; Mark J Niciu; Erica M Richards; Carlos A Zarate
Journal:  Prim Care Companion CNS Disord       Date:  2014-05-29

2.  A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.

Authors:  Dawn F Ionescu; David A Luckenbaugh; Mark J Niciu; Erica M Richards; Carlos A Zarate
Journal:  Bipolar Disord       Date:  2014-11-14       Impact factor: 6.744

3.  Ziprasidone augmentation for anxious depression.

Authors:  Dawn F Ionescu; Richard C Shelton; Lee Baer; Kathryn H Meade; Michaela B Swee; Maurizio Fava; George I Papakostas
Journal:  Int Clin Psychopharmacol       Date:  2016-11       Impact factor: 1.659

4.  Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

Authors:  Elizabeth D Ballard; Dawn F Ionescu; Jennifer L Vande Voort; Mark J Niciu; Erica M Richards; David A Luckenbaugh; Nancy E Brutsché; Rezvan Ameli; Maura L Furey; Carlos A Zarate
Journal:  J Psychiatr Res       Date:  2014-08-12       Impact factor: 4.791

5.  Depressive Symptom Dimensions in Treatment-Resistant Major Depression and Their Modulation With Electroconvulsive Therapy.

Authors:  Benjamin S C Wade; Gerhard Hellemann; Randall T Espinoza; Roger P Woods; Shantanu H Joshi; Ronny Redlich; Anders Jørgensen; Christopher C Abbott; Ketil J Oedegaard; Shawn M McClintock; Leif Oltedal; Katherine L Narr
Journal:  J ECT       Date:  2020-06       Impact factor: 3.692

6.  Instability of default mode network connectivity in major depression: a two-sample confirmation study.

Authors:  T Wise; L Marwood; A M Perkins; A Herane-Vives; R Joules; D J Lythgoe; W-M Luh; S C R Williams; A H Young; A J Cleare; D Arnone
Journal:  Transl Psychiatry       Date:  2017-04-25       Impact factor: 6.222

7.  The Relationship Between Depression Symptoms and Anxiety Symptoms During Acute ECT for Patients With Major Depressive Disorder.

Authors:  Chun-Jen Huang; Ching-Hua Lin; Jyh-I Wu; Wei-Cheng Yang
Journal:  Int J Neuropsychopharmacol       Date:  2019-10-01       Impact factor: 5.176

8.  The association of clinical correlates, metabolic parameters, and thyroid hormones with suicide attempts in first-episode and drug-naïve patients with major depressive disorder comorbid with anxiety: a large-scale cross-sectional study.

Authors:  Yongjie Zhou; Wenchao Ren; Qianqian Sun; Katherine M Yu; Xiaoe Lang; Zezhi Li; Xiang Yang Zhang
Journal:  Transl Psychiatry       Date:  2021-02-04       Impact factor: 7.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.